Literature DB >> 26987869

Determining the Number of Ischemic Strokes Potentially Eligible for Endovascular Thrombectomy: A Population-Based Study.

Nicholas H Chia1, James M Leyden1, Jonathan Newbury1, Jim Jannes1, Timothy J Kleinig2.   

Abstract

BACKGROUND AND
PURPOSE: Endovascular thrombectomy (ET) is standard-of-care for ischemic stroke patients with large vessel occlusion, but estimates of potentially eligible patients from population-based studies have not been published. Such data are urgently needed to rationally plan hyperacute services. Retrospective analysis determined the incidence of ET-eligible ischemic strokes in a comprehensive population-based stroke study (Adelaide, Australia 2009-2010).
METHODS: Stroke patients were stratified via a prespecified eligibility algorithm derived from recent ET trials comprising stroke subtype, pathogenesis, severity, premorbid modified Rankin Score, presentation delay, large vessel occlusion, and target mismatch penumbra. Recognizing centers may interpret recent ET trials either loosely or rigidly; 2 eligibility algorithms were applied: restrictive (key criteria modified Rankin Scale score 0-1, presentation delay <3.5 hours, and target mismatch penumbra) and permissive (modified Rankin Scale score 0-3 and presentation delay <5 hours).
RESULTS: In a population of 148 027 people, 318 strokes occurred in the 1-year study period (crude attack rate 215 [192-240] per 100 000 person-years). The number of ischemic strokes eligible by restrictive criteria was 17/258 (7%; 95% confidence intervals 4%-10%) and by permissive criteria, an additional 16 were identified, total 33/258 (13%; 95% confidence intervals 9%-18%). Two of 17 patients (and 6/33 permissive patients) had thrombolysis contraindications. Using the restrictive algorithm, there were 11 (95% confidence intervals 4-18) potential ET cases per 100 000 person-years or 22 (95% confidence intervals 13-31) using the permissive algorithm.
CONCLUSIONS: In this cohort, ≈7% of ischemic strokes were potentially eligible for ET (13% with permissive criteria). In similar populations, the permissive criteria predict that ≤22 strokes per 100 000 person-years may be eligible for ET.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  brain ischemia; endovascular treatment; epidemiology; stroke; thrombectomy

Mesh:

Year:  2016        PMID: 26987869     DOI: 10.1161/STROKEAHA.116.013165

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  36 in total

1.  Impact of stroke co-morbidities on cortical collateral flow following ischaemic stroke.

Authors:  Ifechukwude J Biose; Deborah Dewar; I Mhairi Macrae; Christopher McCabe
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-24       Impact factor: 6.200

Review 2.  Applications of Focused Ultrasound in Cerebrovascular Diseases and Brain Tumors.

Authors:  Francesco Prada; M Yashar S Kalani; Kaan Yagmurlu; Pedro Norat; Massimiliano Del Bene; Francesco DiMeco; Neal F Kassell
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

3.  Evolution of a US County System for Acute Comprehensive Stroke Care.

Authors:  Radoslav I Raychev; Dana Stradling; Nirav Patel; Joey R Gee; David A Lombardi; Johnson L Moon; David M Brown; Mayank Pathak; Wengui Yu; Samuel J Stratton; Steven C Cramer
Journal:  Stroke       Date:  2018-04-06       Impact factor: 7.914

Review 4.  Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke.

Authors:  Rais Reskiawan A Kadir; Ulvi Bayraktutan
Journal:  Cell Mol Neurobiol       Date:  2019-09-24       Impact factor: 5.046

5.  Intracerebroventricular Delivery of Recombinant NAMPT Deters Inflammation and Protects Against Cerebral Ischemia.

Authors:  Fenghua Chen; Zhongfang Weng; Qinghai Xia; Catherine Cao; Rehana K Leak; Lihong Han; Jian Xiao; Steven H Graham; Guodong Cao
Journal:  Transl Stroke Res       Date:  2019-02-28       Impact factor: 6.829

Review 6.  Unresolved Issues in Thrombectomy.

Authors:  Mahesh V Jayaraman; Ryan A McTaggart; Mayank Goyal
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

7.  Impact of COVID-19 on ischemic stroke care in Hungary.

Authors:  Péter Pál Böjti; Géza Szilágyi; Balázs Dobi; Rita Stang; István Szikora; Balázs Kis; Ákos Kornfeld; Csaba Óváry; Lóránd Erőss; Péter Banczerowski; Wojciech Kuczyński; Dániel Bereczki
Journal:  Geroscience       Date:  2021-08-18       Impact factor: 7.713

8.  Number of ischemic strokes potentially eligible for revascularization treatments in an Italian Comprehensive Stroke Center: a modeling study.

Authors:  Stefano Forlivesi; Bruno Bonetti; Manuel Cappellari
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

Review 9.  Clinical perspectives on ischemic stroke.

Authors:  Atsushi Mizuma; Midori A Yenari
Journal:  Exp Neurol       Date:  2021-01-10       Impact factor: 5.330

10.  Emerging Artificial Intelligence Imaging Applications for Stroke Interventions.

Authors:  E Lotan
Journal:  AJNR Am J Neuroradiol       Date:  2020-12-31       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.